154 related articles for article (PubMed ID: 18635312)
1. Histone deacetylase inhibitors and genomic instability.
Eot-Houllier G; Fulcrand G; Magnaghi-Jaulin L; Jaulin C
Cancer Lett; 2009 Feb; 274(2):169-76. PubMed ID: 18635312
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors: roles of DNA damage and repair.
Robert C; Rassool FV
Adv Cancer Res; 2012; 116():87-129. PubMed ID: 23088869
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.
Magnaghi-Jaulin L; Eot-Houllier G; Fulcrand G; Jaulin C
Cancer Res; 2007 Jul; 67(13):6360-7. PubMed ID: 17616695
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cellular radiation responses by histone deacetylase inhibitors.
Karagiannis TC; El-Osta A
Oncogene; 2006 Jun; 25(28):3885-93. PubMed ID: 16462761
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors induce mitotic slippage.
Stevens FE; Beamish H; Warrener R; Gabrielli B
Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
Frew AJ; Johnstone RW; Bolden JE
Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
[TBL] [Abstract][Full Text] [Related]
9. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
[TBL] [Abstract][Full Text] [Related]
10. The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells.
Portanova P; Russo T; Pellerito O; Calvaruso G; Giuliano M; Vento R; Tesoriere G
Int J Oncol; 2008 Aug; 33(2):325-31. PubMed ID: 18636153
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
Toyooka T; Ibuki Y
Cancer Res; 2009 Apr; 69(8):3492-500. PubMed ID: 19351858
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
13. Studies of benzamide- and thiol-based histone deacetylase inhibitors in models of oxidative-stress-induced neuronal death: identification of some HDAC3-selective inhibitors.
Chen Y; He R; Chen Y; D'Annibale MA; Langley B; Kozikowski AP
ChemMedChem; 2009 May; 4(5):842-52. PubMed ID: 19350613
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
Emanuele S; Lauricella M; Tesoriere G
Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
[TBL] [Abstract][Full Text] [Related]
15. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
17. Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
Lucas JL; Mirshahpanah P; Haas-Stapleton E; Asadullah K; Zollner TM; Numerof RP
Cell Immunol; 2009; 257(1-2):97-104. PubMed ID: 19358983
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a series of potent and selective ketone histone deacetylase inhibitors.
Pescatore G; Kinzel O; Attenni B; Cecchetti O; Fiore F; Fonsi M; Rowley M; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
Bioorg Med Chem Lett; 2008 Oct; 18(20):5528-32. PubMed ID: 18809328
[TBL] [Abstract][Full Text] [Related]
19. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.
Bose P; Dai Y; Grant S
Pharmacol Ther; 2014 Sep; 143(3):323-36. PubMed ID: 24769080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
